Literature DB >> 14698197

7-Hydroxynaphthalen-1-yl-urea and -amide antagonists of human vanilloid receptor 1.

Mark E McDonnell1, Sui Po Zhang, Nadia Nasser, Adrienne E Dubin, Scott L Dax.   

Abstract

A series of structurally simple 7-hydroxynaphthalenyl ureas and amides were discovered to be potent ligands of human vanilloid receptor 1 (VR1). 1-(7-Hydroxynaphthalen-1-yl)-3-(4-trifluoromethylbenzyl)urea 5f exhibited nanomolar binding affinity (K(i)=1.0nM) and upon capsaicin challenge, behaved as a potent functional antagonist (IC(50)=4nM). The synthesis and structure-activity relationships (SARs) for the series are described.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14698197     DOI: 10.1016/j.bmcl.2003.09.090

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  3 in total

1.  Discovery of dual-acting opioid ligand and TRPV1 antagonists as novel therapeutic agents for pain.

Authors:  Hobin Lee; Songyeon Ahn; Jihyae Ann; Heejin Ha; Young Dong Yoo; Young Ho Kim; Ji-Young Hwang; Kwang-Hyun Hur; Choon-Gon Jang; Larry V Pearce; Timothy E Esch; Nancy E Lewin; Peter M Blumberg; Jeewoo Lee
Journal:  Eur J Med Chem       Date:  2019-08-21       Impact factor: 6.514

2.  N,N'-Bis(4-fluoro-phen-yl)urea.

Authors:  Wan-Sin Loh; Hoong-Kun Fun; S Sarveswari; V Vijayakumar; R Venkat Ragavan
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-05-12

3.  Novel scaffolds for modulation of TRPV1 identified with pharmacophore modeling and virtual screening.

Authors:  Daria Goldmann; Peter Pakfeifer; Steffen Hering; Gerhard F Ecker
Journal:  Future Med Chem       Date:  2015       Impact factor: 4.767

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.